Patient-specific insulin dosing for hospitals
Monarch Medical Technologies (monarchmedtech.com) earns a Brand Analyzer score of 70 out of 100, placing it in the Developing tier among Healthcare brands, Technology brands. Among 2305 Healthcare brands analyzed, Monarch Medical Technologies ranks in the 62nd percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 75/100, Digital Presence 82/100, Visual Identity 96/100, Messaging Clarity 95/100, Trust Foundation 66/100, AI Discoverability 86/100, Brand Authority 23/100.
Monarch Medical Technologies, a Glooko Company, develops and provides EndoTool®, a patient-specific insulin dosing system designed to improve glycemic management in hospital and healthcare enterprise settings. The company has operated for over 20 years and positions its technology as a precision tool for critical care clinicians. EndoTool® offers personalized insulin therapy, actionable analytics, and advanced glycemic control capabilities aimed at reducing complications in inpatient care.
| Brand Name | Monarch Medical Technologies |
|---|---|
| Domain | monarchmedtech.com |
| Industry | Healthcare, Technology |
| Parent Company / Owner | Glooko |
| Main Competitors | Glytec (74/100), Becton Dickinson (80/100), Dexcom (84/100), Abbott Diabetes Care (91/100), Medtronic Diabetes |
Moz Domain Authority 32/100 vs category average 29 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Discover Monarch Medical Technologies, a Glooko Company and EndoTool®, the leading patient-specific insulin dosing system, improving glycemic management for over 20 years." (Meta description: 22 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, Facebook, Instagram, YouTube; no detected presence on X (Twitter), GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Monarch Medical Technologies scores 29/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Monarch Medical Technologies has a weak AI-visibility profile at 29/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (58/100) and its weakest is visibility (0/100). It benefits from open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 32/100.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Monarch Medical Technologies offers EndoTool®, a patient-specific insulin dosing system designed for hospitals and healthcare enterprises. EndoTool® provides personalized insulin management, advanced glycemic control, and actionable insights and analytics. The system is designed to deliver safe, simple, and precise insulin therapy tailored to individual patients, supporting critical care clinicians in managing blood glucose levels effectively within inpatient healthcare settings.
Monarch Medical Technologies's main competitors include Glytec (74/100), Becton Dickinson (80/100), Dexcom (84/100), Abbott Diabetes Care (91/100), Medtronic Diabetes. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Monarch Medical Technologies and Abbott Diabetes Care are competitors in Healthcare. Brand Analyzer scores Monarch Medical Technologies at 70/100 and Abbott Diabetes Care at 91/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Monarch Medical Technologies is a healthcare technology company and a Glooko Company that provides EndoTool®, a patient-specific insulin dosing system. The company focuses on glycemic management solutions for hospitals and healthcare enterprises. With more than 20 years of operation, it positions itself as a trusted provider of precision insulin dosing solutions designed to help hospitals achieve superior glycemic control and reduce patient complications.
Popular alternatives to Monarch Medical Technologies include Glytec (74/100), Becton Dickinson (80/100), Dexcom (84/100), Abbott Diabetes Care (91/100), Medtronic Diabetes. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Monarch Medical Technologies has limited AI-search visibility, scoring 29/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 48, recommendation 58). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Monarch Medical Technologies is known for EndoTool®, described as the leading patient-specific insulin dosing system. The company is recognized for over 20 years of experience in improving glycemic management in hospitals and healthcare enterprises. EndoTool® is particularly noted for delivering personalized insulin management supported by advanced technology, actionable analytics, and a focus on safe and precise insulin therapy for inpatient settings.
Monarch Medical Technologies' products are used by hospitals, healthcare enterprises, and critical care clinicians. The target audience includes healthcare professionals and organizations seeking advanced glycemic management and insulin dosing technology. The company's EndoTool® system is specifically designed for inpatient settings where precise and personalized insulin therapy is required to improve patient outcomes and reduce complications related to glycemic control.
Monarch Medical Technologies scores 58/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Monarch Medical Technologies can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Monarch Medical Technologies is described as a leading provider of patient-specific insulin dosing systems, with over 20 years of presence in the healthcare technology market. Its EndoTool® system is positioned as a trusted solution for hospitals and healthcare enterprises seeking advanced glycemic management. The combination of personalized insulin therapy, analytics, and a long operational track record contributes to its recognition among critical care clinicians and hospital systems.
Ranked closest to Monarch Medical Technologies: MJHS Health System (70/100), Montreal General Hospital Foundation (70/100), Movn Health (70/100), Moxe (70/100).
A step up - brands to learn from: Zipari by mPulse (71/100), Zaina AI (71/100).
Category leader: Dassault Systèmes (95/100).